AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28398597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod (dose-escalation regimen)
Number of subjects: 88
Study 26902061 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative visits with nurses and conventional nursing care
Number of subjects: 240
Study 26902061 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 240
Study 23167508 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid withdrawal (CSWD)
Number of subjects: 397
Study 23167508 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid continuance (CCS)
Number of subjects: 397
Study 21212429 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 571
Study 21212429 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 571
Study 18079616 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO)
Number of subjects: 0
Study 18079616 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of targeted agents or chemotherapy
Number of subjects: 0
Study 18079616 — intervention group
Group type: EXPERIMENTAL
Intervention: Other targeted agents (tyrosine kinase inhibitors, farnesyl transferase inhibitor)
Number of subjects: 0
Study 16432953 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 162 (3.0 mg/kg)
Number of subjects: 49
Study 16432953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 16432953 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 162
Number of subjects: 49
Study 12353708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice starch added to bath water (twice daily for 15 min)
Number of subjects: 0
Study 12353708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-starch-containing lipid-free bath formulation
Number of subjects: 0
Study 12353708 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-in-water bath lotion enriched with evening primrose oil
Number of subjects: 0
Study 12353708 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice starch powder added to bath water
Number of subjects: 0
Study 10203664 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy
Number of subjects: 48
Study 10203664 — intervention group
Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 48
Study 7887873 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR)
Number of subjects: 38
Study 7887873 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 38
Study 7887873 — intervention group
Group type: COMPARATOR
Intervention: Both AR and CBT
Number of subjects: 38
Study 2368979 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital diet
Number of subjects: 9
Study 2368979 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital diet with supplementation
Number of subjects: 9
Study 345484 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolept analgesia with topical anaesthesia
Number of subjects: 142
Study 345484 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolept analgesia without topical anaesthesia
Number of subjects: 142
Study 345484 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic and topical anaesthesia with diazepam
Number of subjects: 142
Study 345484 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic and topical anaesthesia without diazepam
Number of subjects: 142
Study 29734112 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-locking stand-alone cage
Number of subjects: 98
Study 29734112 — intervention group
Group type: COMPARATOR
Intervention: Cages with anterior cervical plating system
Number of subjects: 98
Study 27117505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip arthroscopy
Number of subjects: 42
Study 27117505 — intervention group
Group type: COMPARATOR
Intervention: Best conservative care (personalised hip therapy)
Number of subjects: 42
Study 25128518 — intervention group
Group type: EXPERIMENTAL
Intervention: Multibiomarker disease activity (MBDA) score
Number of subjects: 180
Study 25128518 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Activity Score (DAS)
Number of subjects: 180
Study 22421921 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy (TE)
Number of subjects: 76
Study 22421921 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial intra capsular tonsillectomy/tonsillotomy (TT)
Number of subjects: 76
Study 22421921 — intervention group
Group type: COMPARATOR
Intervention: Both TE and TT
Number of subjects: 76
Study 20377533 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Plus (n = 168)
Number of subjects: 304
Study 20377533 — intervention group
Group type: COMPARATOR
Intervention: Standard-MD (n = 136)
Number of subjects: 304
Study 20377533 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly educated mothers (Video-Plus)
Number of subjects: 304
Study 18693478 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified rice (daily portion of cooked rice 5 days per week for 6 months)
Number of subjects: 0
Study 18693478 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 0
Study 16471105 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 MAC sevoflurane
Number of subjects: 20
Study 16471105 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 MAC sevoflurane
Number of subjects: 20
Study 16471105 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 MAC sevoflurane
Number of subjects: 20
Study 16471105 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 MAC sevoflurane
Number of subjects: 20
Study 12699051 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing and rinsing with an essential oil‐containing mouthrinse (BEO group)
Number of subjects: 326
Study 12699051 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing and flossing (BF group)
Number of subjects: 326
Study 12699051 — intervention group
Group type: COMPARATOR
Intervention: Brushing and rinsing with a control rinse (B group)
Number of subjects: 326
Study 10755496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 1473
Study 10755496 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentermine/fenfluramine
Number of subjects: 1473
Study 10755496 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 1473
Study 10755496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine and phentermine/fenfluramine
Number of subjects: 1473
Study 8751743 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (alpha‐tocopherol) 200 mg daily by mouth for 3 months
Number of subjects: 15
Study 1413198 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 60
Study 1413198 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 60
Study 3933889 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC plus canopy
Number of subjects: 0
Study 28560503 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplemented with an additional 480 g of fruit and vegetables and 300 ml of fruit juice daily for 12 weeks
Number of subjects: 45
Study 28560503 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 45
Study 26728182 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical vagal nerve stimulation (t-VNS) and deep slow breathing (DSB)
Number of subjects: 18
Study 26728182 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 18
Study 25044127 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 25044127 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study 22150569 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ATCC 55730 enema (10^10 CFU) for 8 weeks
Number of subjects: 40
Study 20598855 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein, arginine- and micronutrient-enriched oral nutritional supplement (ONS)
Number of subjects: 43
Study 18052564 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily
Number of subjects: 327
Study 18052564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study 16140220 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic bronchitis patients
Number of subjects: 68
Study 16140220 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 68
Study 12297206 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-ketoglutarate enriched enteral nutrition (n = 11)
Number of subjects: 20
Study 12297206 — intervention group
Group type: COMPARATOR
Intervention: Standard whole-protein-based enteral nutrition (n = 9)
Number of subjects: 20
Study 10488999 — intervention group
Group type: EXPERIMENTAL
Intervention: H-wave therapy (HWT)
Number of subjects: 48
Study 10488999 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 48
Study 10488999 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 48
Study 8888163 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory rehabilitation (exercise training for at least 4 weeks)
Number of subjects: 14
Study 8888163 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 14
Study 1998627 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocket spatula
Number of subjects: 533
Study 1998627 — intervention group
Group type: COMPARATOR
Intervention: Ayre spatula
Number of subjects: 533
Study 6151741 — intervention group
Group type: EXPERIMENTAL
Intervention: Bopindolol 1 mg
Number of subjects: 33
Study 6151741 — intervention group
Group type: EXPERIMENTAL
Intervention: Bopindolol 2 mg
Number of subjects: 33
Study 6151741 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 33
Study 6151741 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 33
Study 6151741 — intervention group
Group type: EXPERIMENTAL
Intervention: Bopindolol
Number of subjects: 33
Study 31296113 — intervention group
Group type: EXPERIMENTAL
Intervention: APA-Stroke
Number of subjects: 76
Study 31296113 — intervention group
Group type: COMPARATOR
Intervention: Sittercise
Number of subjects: 76
Study 29551618 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral quetiapine 400 mg daily (maintenance treatment)
Number of subjects: 178
Study 29551618 — intervention group
Group type: COMPARATOR
Intervention: Placebo (early treatment discontinuation)
Number of subjects: 178
Study 26882318 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine + levodopa
Number of subjects: 967
Study 26882318 — intervention group
Group type: COMPARATOR
Intervention: Placebo + levodopa
Number of subjects: 967
Study 23180371 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml 1% lidocaine injection
Number of subjects: 48
Study 23180371 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 48
Study 21958882 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 2502
Study 21958882 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 2502
Study 21958882 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprocedural stroke
Number of subjects: 2502
Study 21958882 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial infarction (MI)
Number of subjects: 2502
Study 21958882 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprocedural cranial nerve palsy
Number of subjects: 2502
Study 19333156 — intervention group
Group type: EXPERIMENTAL
Intervention: oxymorphone ER
Number of subjects: 140
Study 19333156 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study 17034640 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 549
Study 17034640 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 549
Study 15522048 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT perfusion imaging
Number of subjects: 30
Study 11493853 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a back belt
Number of subjects: 28
Study 11493853 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a back belt while lifting large boxes
Number of subjects: 28
Study 9165656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia
Number of subjects: 0
Study 8335427 — intervention group
Group type: EXPERIMENTAL
Intervention: benazepril a.m. (10 mg)
Number of subjects: 10
Study 8335427 — intervention group
Group type: EXPERIMENTAL
Intervention: benazepril p.m. (10 mg)
Number of subjects: 10
Study 8335427 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 3561954 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival cefotaxime 100 mg
Number of subjects: 30
Study 3561954 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular cefotaxime 1000 mg
Number of subjects: 30
Study 28627862 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable devices for upper limb rehabilitation (15 daily sessions at least three times a week for 5 weeks)
Number of subjects: 18
Study 28627862 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable devices for upper limb rehabilitation
Number of subjects: 18
Study 28627862 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (control group)
Number of subjects: 18
Study 27514445 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded polytetrafluoroethylene stent graft
Number of subjects: 275
Study 27514445 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (PTA)
Number of subjects: 275
Study 24796057 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric acupuncture stimulator (needle-retaining group)
Number of subjects: 90
Study 24796057 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient controlled intravenous analgesia (analgesia-pumper group)
Number of subjects: 90
Study 24796057 — intervention group
Group type: COMPARATOR
Intervention: No analgesia (control group)
Number of subjects: 90
Study 22703865 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (7% mean weight loss at 6 months)
Number of subjects: 344
Study 22703865 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (6% mean weight loss at 12 months)
Number of subjects: 344
Study 22703865 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 344
Study 20403941 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage (0.4 g/kg)
Number of subjects: 28
Study 20403941 — intervention group
Group type: COMPARATOR
Intervention: Control beverage (nonalcoholic)
Number of subjects: 28
Study 18256140 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg/day
Number of subjects: 9
Study 18256140 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 98 mg/day
Number of subjects: 9
Study 18256140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 18256140 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg/day (26-h delay)
Number of subjects: 9
Study 18256140 — intervention group
Group type: COMPARATOR
Intervention: Placebo (26-h delay)
Number of subjects: 9
Study 18256140 — intervention group
Group type: EXPERIMENTAL
Intervention: ACh iontophoresis
Number of subjects: 9
Study 18256140 — intervention group
Group type: EXPERIMENTAL
Intervention: Postocclusive hyperemia
Number of subjects: 9
Study 19727071 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral GLP-1 (2 mg)
Number of subjects: 16
Study 19727071 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GLP-1)
Number of subjects: 16
Study 16107222 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy
Number of subjects: 600
Study 16107222 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 600
Study 12215552 — intervention group
Group type: EXPERIMENTAL
Intervention: (186)Re-etidronate
Number of subjects: 111
Study 9609801 — intervention group
Group type: EXPERIMENTAL
Intervention: Microgravity (0 G head‐to‐foot acceleration)
Number of subjects: 5
Study 9609801 — intervention group
Group type: EXPERIMENTAL
Intervention: Postflight day 1 measurements
Number of subjects: 5
Study 7928150 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast conserving treatment (BCT)
Number of subjects: 0
Study 7928150 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow marginal tumor excision with aggressive radiation
Number of subjects: 0
Study 7928150 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide resection with a small dose of radiation
Number of subjects: 0
Study 3145375 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative enteral alimentation
Number of subjects: 0
Study 3145375 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral alimentation
Number of subjects: 0
Study 11449182 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol therapy (TTS) 50 mg/day for 6 months
Number of subjects: 362
Study 11449182 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 362
Study 30948560 — intervention group
Group type: EXPERIMENTAL
Intervention: Home food gardening intervention (receiving 2 years of support designing, installing and maintaining a home food garden of at least 80 square feet)
Number of subjects: 100
Study 30948560 — intervention group
Group type: EXPERIMENTAL
Intervention: Home food gardening intervention
Number of subjects: 100
Study 30948560 — intervention group
Group type: COMPARATOR
Intervention: Delayed-intervention control (receiving same gardening support after 2 years of data collection)
Number of subjects: 100
Study 30289357 — intervention group
Group type: EXPERIMENTAL
Intervention: Societal-gain frame
Number of subjects: 299
Study 30289357 — intervention group
Group type: COMPARATOR
Intervention: Societal-loss frame
Number of subjects: 299
Study 26086897 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous interferential electrical stimulation (IFES) + standard urotherapy
Number of subjects: 36
Study 26086897 — intervention group
Group type: COMPARATOR
Intervention: Standard urotherapy
Number of subjects: 36
Study 25456811 — intervention group
Group type: EXPERIMENTAL
Intervention: TMCP training
Number of subjects: 31
Study 25456811 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 31
Study 22592761 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernosal injection (ICI) with 30-60 mg papaverine
Number of subjects: 25
Study 22592761 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 100 mg
Number of subjects: 25
Study 22592761 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil 20 mg
Number of subjects: 25
Study 19853678 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate, 35 mg once weekly (RIS)
Number of subjects: 67
Study 19853678 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 67
Study 17697972 — intervention group
Group type: EXPERIMENTAL
Intervention: BU4 (0.8 mg/kg, over 2 hours 4 times a day)
Number of subjects: 60
Study 17697972 — intervention group
Group type: COMPARATOR
Intervention: BU1 (3.2 mg/kg, over 3 hours once a day)
Number of subjects: 60
Study 17697972 — intervention group
Group type: EXPERIMENTAL
Intervention: BU4
Number of subjects: 60
Study 17697972 — intervention group
Group type: COMPARATOR
Intervention: BU1
Number of subjects: 60
Study 16145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (50 microg/day) continuously and transdermal norethisterone (250 microg/day for 14 days of every 28‐day cycle)
Number of subjects: 81
Study 16145317 — intervention group
Group type: COMPARATOR
Intervention: Control group (95 women with viral chronic hepatitis but without climacteric symptoms)
Number of subjects: 81
Study 16145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol and norethisterone
Number of subjects: 81
Study 11879884 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinding (double blind)
Number of subjects: 0
Study 11879884 — intervention group
Group type: COMPARATOR
Intervention: Blinding (not specified)
Number of subjects: 0
Study 10424412 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback during passive motion reproduction
Number of subjects: 0
Study 10424412 — intervention group
Group type: COMPARATOR
Intervention: Passive motion reproduction without visual feedback
Number of subjects: 0
Study 10424412 — intervention group
Group type: EXPERIMENTAL
Intervention: Different velocity profiles (constant, sinusoidal, complex) during passive displacements
Number of subjects: 0
Study 10424412 — intervention group
Group type: EXPERIMENTAL
Intervention: 2AFC task for distance discrimination
Number of subjects: 0
Study 7778464 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% carbohydrate solution with 7 g L‐1 of branched‐chain amino acids (BCAA)
Number of subjects: 5
Study 7778464 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% carbohydrate solution (CHO)
Number of subjects: 5
Study 7778464 — intervention group
Group type: COMPARATOR
Intervention: Flavoured water
Number of subjects: 5
Study 7778464 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + BCAA
Number of subjects: 5
Study 7778464 — intervention group
Group type: COMPARATOR
Intervention: CHO alone
Number of subjects: 5
Study 2113590 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C instillation
Number of subjects: 419
Study 2113590 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin instillation
Number of subjects: 419
Study 2113590 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of long-term and short-term instillation protocols
Number of subjects: 419
Study 2113590 — intervention group
Group type: COMPARATOR
Intervention: Short-term instillation protocols
Number of subjects: 419
Study 2113590 — intervention group
Group type: COMPARATOR
Intervention: Long-term instillation protocols
Number of subjects: 419
Study 104342 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of oral amphetamine sulfate
Number of subjects: 24
Study 104342 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg of oral anileridine dihydrochloride
Number of subjects: 24
Study 104342 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amphetamine and anileridine
Number of subjects: 24
Study 104342 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 24